Royal Bank of Canada
ASXC

Royal Bank of Canada’s Asensus Surgical, Inc. ASXC Stock Holding History

Royal Bank of Canada’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,489
Closed – – 7689
2024
Q2 		$0 Sell
1,489
-231
-13% -$62 ﹤0.01% 7696
2024
Q1 		$0 Buy
1,720
+133
+8% +$39 ﹤0.01% 7762
2023
Q4 		$0 Sell
1,587
-1,138
-42% -$293 ﹤0.01% 7727
2023
Q3 		$1K Buy
2,725
+2,416
+782% +$878 ﹤0.01% 6981
2023
Q2 		$0 Sell
309
-773
-71% -$462 ﹤0.01% 7780
2023
Q1 		$0 Sell
1,082
-293
-21% -$198 ﹤0.01% 7616
2022
Q4 		$0 Buy
1,375
+237
+21% +$96 ﹤0.01% 7875
2022
Q3 		$0 Sell
1,138
-2,468
-68% -$1.29K ﹤0.01% 8002
2022
Q2 		$1K Sell
3,606
-38,433
-91% -$17.1K ﹤0.01% 7246
2022
Q1 		$26K Sell
42,039
-37,919
-47% -$29.2K ﹤0.01% 6475
2021
Q4 		$88K Buy
79,958
+17,569
+28% +$27.1K ﹤0.01% 6027
2021
Q3 		$114K Buy
62,389
+18,023
+41% +$40.5K ﹤0.01% 5613
2021
Q2 		$141K Sell
44,366
-9,013
-17% -$22.5K ﹤0.01% 5363
2021
Q1 		$174K Buy
53,379
+31,535
+144% +$114K ﹤0.01% 5062
2020
Q4 		$14K Buy
21,844
+2,549
+13% +$1.17K ﹤0.01% 6242
2020
Q3 		$7K Sell
19,295
-12,443
-39% -$4.82K ﹤0.01% 6058
2020
Q2 		$17K Sell
31,738
-19,729
-38% -$9.52K ﹤0.01% 5663
2020
Q1 		$18K Buy
51,467
+2,623
+5% +$2.74K ﹤0.01% 5599
2019
Q4 		$71K Sell
48,844
-117,310
-71% -$408K ﹤0.01% 5267
2019
Q3 		$1.34M Sell
166,154
-18,039
-10% -$245K ﹤0.01% 3098
2019
Q2 		$3.26M Sell
184,193
-17,703
-9% -$387K ﹤0.01% 2387
2019
Q1 		$6.25M Buy
201,896
+26,042
+15% +$873K ﹤0.01% 1865
2018
Q4 		$5.17M Buy
175,854
+42,461
+32% +$1.93M ﹤0.01% 1952
2018
Q3 		$10.1M Buy
133,393
+38,642
+41% +$2.61M ﹤0.01% 1613
2018
Q2 		$5.37M Buy
94,751
+5,390
+6% +$196K ﹤0.01% 1952
2018
Q1 		$1.98M Buy
89,361
+9,544
+12% +$218K ﹤0.01% 2694
2017
Q4 		$2M Buy
79,817
+36,143
+83% +$1.11M ﹤0.01% 2724
2017
Q3 		$813K Buy
43,674
+11,453
+36% +$133K ﹤0.01% 3401
2017
Q2 		$298K Buy
32,221
+4,695
+17% +$44.7K ﹤0.01% 4070
2017
Q1 		$433K Buy
27,526
+6,673
+32% +$116K ﹤0.01% 3756
2016
Q4 		$352K Sell
20,853
-12,997
-38% -$266K ﹤0.01% 4062
2016
Q3 		$743K Sell
33,850
-483
-1% -$8.83K ﹤0.01% 3374
2016
Q2 		$544K Buy
34,333
+908
+3% +$28.5K ﹤0.01% 3620
2016
Q1 		$1.85M Buy
33,425
+13,301
+66% +$570K ﹤0.01% 2540
2015
Q4 		$649K Buy
20,124
+9,662
+92% +$311K ﹤0.01% 3511
2015
Q3 		$307K Buy
10,462
+5,734
+121% +$213K ﹤0.01% 3961
2015
Q2 		$185K Buy
4,728
+100
+2% +$4.61K ﹤0.01% 4428
2015
Q1 		$176K Buy
4,628
+959
+26% +$36.2K ﹤0.01% 4299
2014
Q4 		$139K Buy
3,669
+2,936
+401% +$121K ﹤0.01% 4567
2014
Q3 		$42K Buy
+733
New +$39.5K ﹤0.01% 5029

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Royal Bank of Canada's ASXC Position: Q3 2024 in Review

Royal Bank of Canada sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 1,489 shares.

Royal Bank of Canada first reported a position in ASXC in Q3 2014 and held it in 40 quarters. The position peaked at $10.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Royal Bank of Canada reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 1,489 Asensus Surgical, Inc. shares in Q3 2024.
  • Royal Bank of Canada first reported a position in Asensus Surgical, Inc. in Q3 2014 and held it in 40 quarters.
  • Royal Bank of Canada's Asensus Surgical, Inc. position peaked at $10.1M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.